BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20205419)

  • 1. S4(13)-PV cell-penetrating peptide forms nanoparticle-like structures to gain entry into cells.
    Padari K; Koppel K; Lorents A; Hällbrink M; Mano M; Pedroso de Lima MC; Pooga M
    Bioconjug Chem; 2010 Apr; 21(4):774-83. PubMed ID: 20205419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of S413-PV cell penetrating peptide with model membranes: relevance to peptide translocation across biological membranes.
    Mano M; Henriques A; Paiva A; Prieto M; Gavilanes F; Simões S; de Lima MC
    J Pept Sci; 2007 May; 13(5):301-13. PubMed ID: 17437249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide.
    Mano M; Teodósio C; Paiva A; Simões S; Pedroso de Lima MC
    Biochem J; 2005 Sep; 390(Pt 2):603-12. PubMed ID: 15907190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into cell-entry mechanisms of CPPs by electron microscopy.
    Padari K; Lorents A; Jokitalo E; Pooga M
    Methods Mol Biol; 2011; 683():181-93. PubMed ID: 21053130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S4(13)-PV cell penetrating peptide and cationic liposomes act synergistically to mediate intracellular delivery of plasmid DNA.
    Trabulo S; Mano M; Faneca H; Cardoso AL; Duarte S; Henriques A; Paiva A; Gomes P; Simões S; de Lima MC
    J Gene Med; 2008 Nov; 10(11):1210-22. PubMed ID: 18729238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S4(13)-PV cell-penetrating peptide induces physical and morphological changes in membrane-mimetic lipid systems and cell membranes: implications for cell internalization.
    Cardoso AM; Trabulo S; Cardoso AL; Lorents A; Morais CM; Gomes P; Nunes C; Lúcio M; Reis S; Padari K; Pooga M; Pedroso de Lima MC; Jurado AS
    Biochim Biophys Acta; 2012 Mar; 1818(3):877-88. PubMed ID: 22230348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acyl moieties: improving Pro-rich peptide uptake inside HeLa cells.
    Fernández-Carneado J; Kogan MJ; Van Mau N; Pujals S; López-Iglesias C; Heitz F; Giralt E
    J Pept Res; 2005 Jun; 65(6):580-90. PubMed ID: 15885117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery.
    Konate K; Crombez L; Deshayes S; Decaffmeyer M; Thomas A; Brasseur R; Aldrian G; Heitz F; Divita G
    Biochemistry; 2010 Apr; 49(16):3393-402. PubMed ID: 20302329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles.
    Säälik P; Niinep A; Pae J; Hansen M; Lubenets D; Langel Ü; Pooga M
    J Control Release; 2011 Jul; 153(2):117-25. PubMed ID: 21420454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
    Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
    Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-SAP: a new, noncytotoxic, and fully protease resistant cell-penetrating peptide.
    Pujals S; Fernández-Carneado J; Ludevid MD; Giralt E
    ChemMedChem; 2008 Feb; 3(2):296-301. PubMed ID: 18058782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular uptake of S413-PV peptide occurs upon conformational changes induced by peptide-membrane interactions.
    Mano M; Henriques A; Paiva A; Prieto M; Gavilanes F; Simões S; Pedroso de Lima MC
    Biochim Biophys Acta; 2006 Mar; 1758(3):336-46. PubMed ID: 16516138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional gold nanoparticle-peptide complexes as cell-targeting agents.
    Sun L; Liu D; Wang Z
    Langmuir; 2008 Sep; 24(18):10293-7. PubMed ID: 18715022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peptide carrier Pep-1 forms biologically efficient nanoparticle complexes.
    Muñoz-Morris MA; Heitz F; Divita G; Morris MC
    Biochem Biophys Res Commun; 2007 Apr; 355(4):877-82. PubMed ID: 17331466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell transduction pathways of transportans.
    Padari K; Säälik P; Hansen M; Koppel K; Raid R; Langel U; Pooga M
    Bioconjug Chem; 2005; 16(6):1399-410. PubMed ID: 16287236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans.
    Ziegler A
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):580-97. PubMed ID: 18045730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast membrane association is a crucial factor in the peptide pep-1 translocation mechanism: a kinetic study followed by surface plasmon resonance.
    Henriques ST; Castanho MA; Pattenden LK; Aguilar MI
    Biopolymers; 2010; 94(3):314-22. PubMed ID: 20049920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-evaluating the role of strongly charged sequences in amphipathic cell-penetrating peptides: a fluorescence study using Pep-1.
    Henriques ST; Costa J; Castanho MA
    FEBS Lett; 2005 Aug; 579(20):4498-502. PubMed ID: 16083883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating peptide-based systems for nucleic acid delivery: a biological and biophysical approach.
    Trabulo S; Cardoso AL; Cardoso AM; Düzgüneş N; Jurado AS; de Lima MC
    Methods Enzymol; 2012; 509():277-300. PubMed ID: 22568911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.